BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 31834465)

  • 1. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation.
    Dwivedi DK; Jena GB
    J Biochem Mol Toxicol; 2023 Jul; 37(7):e23357. PubMed ID: 36999408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1257-1274. PubMed ID: 30066023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
    Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
    J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
    Mu J; Cheng F; Wang Q; Wang X; Zhu W; Ma C; Yin X; Ren B; Lian Y; Du X; Zhang H; Liu S; Zhang S
    J Tradit Chin Med; 2020 Apr; 40(2):253-266. PubMed ID: 32242391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
    Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
    J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulatory role of prime identified compounds in the bioactive fraction of Homalium zeylanicum in high-fat diet fed-streptozotocin-induced type 2 diabetic rats.
    Rout D; Chandra Dash U; Kanhar S; Swain SK; Sahoo AK
    J Ethnopharmacol; 2020 Oct; 260():113099. PubMed ID: 32535241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
    Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
    Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
    Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal protective efficacy of flavonoids from Ocimum basilicum extract in diabetic albino rats: A focus on hypoglycemic, antioxidant, anti-inflammatory and anti-apoptotic activities.
    Othman MS; Khaled AM; Al-Bagawi AH; Fareid MA; Ghany RA; Habotta OA; Abdel Moneim AE
    Biomed Pharmacother; 2021 Dec; 144():112287. PubMed ID: 34649220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways.
    Yong Z; Ruiqi W; Hongji Y; Ning M; Chenzuo J; Yu Z; Zhixuan X; Qiang L; Qibing L; Weiying L; Xiaopo Z
    J Immunol Res; 2021; 2021():4084566. PubMed ID: 34734090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis.
    Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M
    Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
    Yang SJ; Je Lee W; Kim EA; Dal Nam K; Hahn HG; Young Choi S; Cho SW
    Eur J Pharmacol; 2014 Aug; 736():26-34. PubMed ID: 24797782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.